Dipongkor Saha

12PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 25, 2026
Triple-Survival Stereotactic Brain Surgeries for the Intracranial Injections of Glioblastoma Stem-like Cells and Oncolytic Herpes Simplex Viruses.

|Sep 16, 2025
Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors.

Myla Hudson, Robert H Newman, Checo J Rorie

|May 31, 2024
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

Hongbin Wang, Mia Borlongan, Howard L Kaufman

|Apr 10, 2024
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival.

Praveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza

|Oct 20, 2023
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy.

Mia C Borlongan, Dipongkor Saha, Hongbin Wang

|Aug 14, 2023
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy.

Hongbin Wang, Mia Borlongan, Akseli Hemminki

Pageof 2

Frequent Collaborators

5 joint publications

Samuel D Rabkin

3 joint publications

Trieu Nguyen

3 joint publications

Sakib M Moinuddin

3 joint publications

Howard L Kaufman